<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04854226</url>
  </required_header>
  <id_info>
    <org_study_id>SZ_D_069_20-IX-1</org_study_id>
    <nct_id>NCT04854226</nct_id>
  </id_info>
  <brief_title>Protein Turnover in Preterm Infants - Feeding of Target Fortified Breast Milk With Different Macronutrient Composition to Improve Growth</brief_title>
  <official_title>Protein Turnover in Preterm Infants - Feeding of Target Fortified Breast Milk With Different Carbohydrate and Fat Composition to Improve Growth</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Paracelsus Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University Medical Center Rostock</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Klinikum Südstadt, Rostock, Germany</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Paracelsus Medical University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to measure protein turnover rates in preterm infants.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      After being informed about the study and potential risks, all parents giving written informed&#xD;
      consent the principal investigator will determine the eligibility for study entry. Patients&#xD;
      who met the eligibility requirements will be randomized in a double-blind manner in a 1:1&#xD;
      ratio to fortified breast milk with higher fat composition to fortified breast milk with&#xD;
      higher carbohydrate composition. Both groups will receive a stable protein composition. The&#xD;
      participants will receive the intervention for 3 consecutive weeks.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">April 15, 2021</start_date>
  <completion_date type="Anticipated">February 28, 2023</completion_date>
  <primary_completion_date type="Anticipated">August 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
    <masking_description>Doctors, nurses and parents are blinded to the intervention</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>weight gain</measure>
    <time_frame>daily for 3 weeks</time_frame>
    <description>weight gain in gram</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Protein turnover and net protein gain</measure>
    <time_frame>weekly for 3 weeks</time_frame>
    <description>Tracer N15 labelled amino acids</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Protein excretion</measure>
    <time_frame>weekly for 3 weeks</time_frame>
    <description>Urinary urea in mg/dL and urine volume in mL will be combined to report protein excretion per urine sample (g/kg/d).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Nutritional intake</measure>
    <time_frame>daily for 3 weeks</time_frame>
    <description>Volume of Breast Milk in mL/kg/d, Lactose in g/100mL, protein g/100mL, fat g/100mL will be combinded to report energy in kcal/kg/d</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>head circumference</measure>
    <time_frame>daily for 3 weeks</time_frame>
    <description>in cm</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>body length</measure>
    <time_frame>daily for 3 weeks</time_frame>
    <description>in cm</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>body composition</measure>
    <time_frame>weekly for 3 weeks</time_frame>
    <description>Fat mass in g, fat-free mass g, volume in L will be combined to report body density in kg/L</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Infant Development</condition>
  <condition>Protein-energy; Imbalance</condition>
  <condition>Protein Deposition</condition>
  <arm_group>
    <arm_group_label>Macronutrient_CARB</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>High carbs, low fat composition.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Macronutrient_FAT</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Low carbs, high fat composition.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Macronutrients_CARB</intervention_name>
    <description>Breast milk 150 to 170 mL/d; Target fortification: 9.0 g/100mL COH, 3.0 g/100mL protein, 4.0 g/100mL fat, 86.4 kcal/100mL</description>
    <arm_group_label>Macronutrient_CARB</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Macronutrient_FAT</intervention_name>
    <description>Breast milk 150 to 170 mL/d; Target fortification: 5.5 g/100mL COH, 3.0 g/100mL protein, 5.5 g/100mL fat, 86 kcal/100mL</description>
    <arm_group_label>Macronutrient_FAT</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Gestational age &lt; 32 weeks&#xD;
&#xD;
          -  Enteral nutrition &gt;150 mL / kg / d&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  gastrointestinal malformations&#xD;
&#xD;
          -  Enterostoma&#xD;
&#xD;
          -  short bowel syndrome&#xD;
&#xD;
          -  necrotizing enterocolitis&#xD;
&#xD;
          -  kidney disease&#xD;
&#xD;
          -  Foreseeable transfer&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>23 Weeks</minimum_age>
    <maximum_age>32 Weeks</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Christoph Fusch, Prof. Dr. med.</last_name>
    <phone>+49911 398-2307</phone>
    <email>christoph.fusch@klinikum-nuernberg.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Niels Rochow, PD Dr. med.</last_name>
    <phone>+49911-398-118903</phone>
    <email>Niels.Rochow@klinikum-nuernberg.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Klinik für Neugeborene, Kinder und Jugendliche Universitätsklinik der Paracelsus Medizinischen Privatuniversität</name>
      <address>
        <city>Nürnberg</city>
        <zip>90471</zip>
        <country>Germany</country>
      </address>
    </facility>
    <contact>
      <last_name>Christoph Fusch, Prof. Dr. med.</last_name>
      <phone>+49911398-2307</phone>
      <email>christoph.fusch@klinikum-nuernberg.de</email>
    </contact>
    <contact_backup>
      <last_name>Niels Rochow, PD Dr. med.</last_name>
      <phone>+49911398-118903</phone>
      <email>Niels.Rochow@klinikum-nuernberg.de</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Universitätsmedizin Rostock Kinder und Jugendklinik</name>
      <address>
        <city>Rostock</city>
        <zip>18057</zip>
        <country>Germany</country>
      </address>
    </facility>
    <contact>
      <last_name>Jan Däbritz, Prof. Dr. med.</last_name>
      <phone>+49381-494 7001</phone>
      <email>jan.daebritz@med.uni-rostock.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Klinikum Südstadt Rostock Abteilung für Neonatologie und Neonatologische Intensivmedizin</name>
      <address>
        <city>Rostock</city>
        <zip>18059</zip>
        <country>Germany</country>
      </address>
    </facility>
    <contact>
      <last_name>Dirk Manfred Olbertz, PD Dr . med.</last_name>
      <phone>+49381 4401</phone>
      <phone_ext>5500</phone_ext>
      <email>dirk.olbertz@kliniksued-rostock.de</email>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>April 12, 2021</study_first_submitted>
  <study_first_submitted_qc>April 16, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 22, 2021</study_first_posted>
  <last_update_submitted>April 16, 2021</last_update_submitted>
  <last_update_submitted_qc>April 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 22, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Paracelsus Medical University</investigator_affiliation>
    <investigator_full_name>Niels Rochow, MD, PhD</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>protein turnover</keyword>
  <keyword>growth</keyword>
  <keyword>tracer</keyword>
  <keyword>macronutrients</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

